# Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk

> **NCT01104220** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 144 (estimated)

## Conditions studied

- Non-alcoholic Fatty Liver Disease
- Metabolic Syndrome
- Metabolically Abnormal Obesity
- Metabolically Normal Obesity
- Obesity

## Interventions

- **OTHER:** Weight loss

## Key facts

- **NCT ID:** NCT01104220
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2010-04
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2025-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104220, "Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01104220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*